General A $480,000-a-Year Pill Reflects a New Normal for Cancer DrugsBy Healthcare Propulsion StaffAugust 31, 20260 Revolution Medicines set a sticker price of about $480,000 a year, or $663 a tablet, for its new pancreatic cancer…
Research Stage 4 Maine cancer patient says new FDA-approved pill is buying him timeBy Healthcare Propulsion StaffAugust 27, 20260 PORTLAND, Maine (WGME) — It’s potentially new hope for pancreatic cancer patients.The FDA has just given approval to a new…
Research The GLP-1 Pill Era Is Forcing Beauty to Change AgainBy Healthcare Propulsion StaffAugust 21, 20260 Beauty gets more intimateThe final frontier is one largely absent from early GLP-1 beauty conversations: sexual wellness. As bodies change…
